New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together
In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators
NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”
NCAB Member Seeks Broder’s Resignation, Gets No support
Pittsburgh Broadens Misconduct Inquiry
Senate Appropriators Plan Hearing On NCI Ouster Of Fisher
DCE director Adamson To Retire August 31
DCPC Advisor O Trial Of Cervical Lesion Management With HPV
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









